OpenArc Corporate Advisory, LLC

Source: SEC Form 13F · as of Mar 2026

OpenArc Corporate Advisory, LLC holds 45 biotech & pharma companies tracked by BioSniper, totaling $213.6M in value as of Mar 2026 (SEC Form 13F).

Companies held

45

Total value held

$213.6M

CompanySharesValue
AMGNAMGEN INC244,828$86.1M
LLYELI LILLY & Co25,315$23.3M
JNJJOHNSON & JOHNSON92,618$22.6M
ABBVAbbVie Inc.98,522$21.4M
UNHUnitedHealth Group Incorporated Common Stock (DE)43,799$11.9M
MRKMerck & Co., Inc.54,298$6.5M
GILDGILEAD SCIENCES, INC.45,449$6.3M
AZNASTRAZENECA PLC26,651$5.3M
ABTABBOTT LABORATORIES29,068$3.0M
PMPhilip Morris International Inc15,485$2.6M
KNSAKiniksa Pharmaceuticals International, plc48,353$2.3M
CORCencora Inc.6,848$2.2M
NVSNovartis AG12,778$2.0M
BMYBRISTOL MYERS SQUIBB CO29,272$1.8M
GLUEMonte Rosa Therapeutics, Inc.100,227$1.6M
PFEPFIZER INC48,745$1.4M
HALOHALOZYME THERAPEUTICS, INC.19,987$1.3M
CAHCardinal Health Inc.6,010$1.3M
VRTXVERTEX PHARMACEUTICALS INC / MA2,395$1.1M
TVTXTravere Therapeutics, Inc.31,000$921K
ARQTArcutis Biotherapeutics, Inc.30,593$721K
MCKMcKesson Corporation738$639K
REGNREGENERON PHARMACEUTICALS, INC.809$625K
PBYIPUMA BIOTECHNOLOGY, INC.89,491$572K
GMOptec International, Inc.7,162$534K
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)9,553$527K
ELVElevance Health Inc.1,689$494K
VTRSViatris Inc36,444$492K
ALLOAllogene Therapeutics, Inc.172,258$420K
ARGXARGENX SE499$364K
NVONovo Nordisk A/S8,972$330K
ALMSALUMIS INC.14,240$314K
IQVIQVIA Holdings Inc.1,756$299K
GEHCGE HealthCare Technologies Inc.4,150$295K
SNYSanofi5,592$269K
IDXXIDEXX LABORATORIES INC /DE457$257K
ZBHZimmer Biomet Holdings Inc.2,717$246K
JAZZJazz Pharmaceuticals plc1,297$245K
ONCBeOne Medicines Ltd.789$234K
RPRXRoyalty Pharma plc4,761$228K
DGXQuest Diagnostics Incorporated1,140$223K
INSMINSMED Inc1,334$218K
VRDNViridian Therapeutics, Inc.\DE10,038$196K
MBOTMicrobot Medical Inc.10,000$24K
ONMDOneMedNet Corp11,342$10K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.